TNFSF10 and breast carcinoma: Whereas, in MDA-MB-231 breast cancer cells, an increase in apoptosis is observed from 20–30% in BV6 combined with TRAIL and TNFα compared to individual treatment with TRAIL and TNFα, i.e., 25–41% (Figure 5c).